326 filings
Page 5 of 17
SC 13G/A
Dexcel Pharma Technologies Ltd.
5 Feb 20
Intec Pharma Ltd.
11:14am
4
Dexcel Pharma Technologies Ltd.
4 Feb 20
Intec Pharma / Dan Oren ownership change
6:41pm
8-K
INDP
Indaptus Therapeutics Inc
3 Feb 20
Entry into a Material Definitive Agreement
5:28pm
424B5
INDP
Indaptus Therapeutics Inc
3 Feb 20
Prospectus supplement for primary offering
5:27pm
424B5
INDP
Indaptus Therapeutics Inc
30 Jan 20
Prospectus supplement for primary offering
4:40pm
8-K
INDP
Indaptus Therapeutics Inc
11 Dec 19
Intec Pharma Provides Update on Novartis Feasibility and Option Agreement
7:48am
8-K
INDP
Indaptus Therapeutics Inc
3 Dec 19
Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement with Aspire Capital
7:40am
424B5
INDP
Indaptus Therapeutics Inc
3 Dec 19
Prospectus supplement for primary offering
7:39am
8-K
INDP
Indaptus Therapeutics Inc
2 Dec 19
Departure of Directors or Certain Officers
5:21pm
4
INDP
Indaptus Therapeutics Inc
21 Nov 19
Intec Pharma / Issac Silberman ownership change
5:00pm
10-Q
2019 Q3
INDP
Indaptus Therapeutics Inc
Quarterly report
12 Nov 19
4:18pm
8-K
INDP
Indaptus Therapeutics Inc
12 Nov 19
Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update
4:15pm
DEF 14A
INDP
Indaptus Therapeutics Inc
Definitive proxy
25 Oct 19
4:15pm
PRE 14A
INDP
Indaptus Therapeutics Inc
Preliminary proxy
7 Oct 19
4:52pm
8-K
INDP
Indaptus Therapeutics Inc
27 Sep 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:16pm
4
Nir Sassi
16 Sep 19
Intec Pharma / Nir Sassi ownership change
9:32pm
4
Walt Addison Linscott
16 Sep 19
Intec Pharma / Walt Addison Linscott ownership change
9:28pm
8-K
INDP
Indaptus Therapeutics Inc
16 Sep 19
Departure of Directors or Certain Officers
8:08am
8-K
INDP
Indaptus Therapeutics Inc
9 Sep 19
Regulation FD Disclosure
8:01am
8-K
INDP
Indaptus Therapeutics Inc
5 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:17pm